Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / ADR
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
2,672,544
-
Shares change
-
-312,962,534
-
Total reported value, excl. options
-
$78,738,323
-
Value change
-
-$13,603,554,693
-
Number of buys
-
7
-
Number of sells
-
798
-
Price
-
$29.43
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q3 2022
As of 30 Sep 2022 GLAXOSMITHKLINE PLC - ADR (GSK) had 834 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,672,544 shares of stock of the company.
Largest 10 holders included KAHN BROTHERS GROUP INC, Tri Locum Partners LP, Keystone Financial Planning, Inc., Tweedy, Browne Co LLC, HOURGLASS CAPITAL, LLC, MACQUARIE GROUP LTD, ADVISORS MANAGEMENT GROUP INC /ADV, Old Port Advisors, Knott David M Jr, and Elevated Capital Advisors, LLC.
This table shows 834 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.